# Voyager Therapeutics, Inc.: Form 8-K, filed Jul 10, 2023

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2023-07-10
- Accepted by EDGAR: Jul 10, 2023, 08:04 ET
- Period: 2023-07-05
- Accession: 0001104659-23-079340
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/tm2320812d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/tm2320812d1_8k.htm

Filed Jul 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-079340. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.